Evidence map›Paper›PMID 35155187›Full record

ArticleFrontiers in oncology2021

Ethyl Ferulate Suppresses Esophageal Squamous Cell Carcinoma Tumor Growth Through Inhibiting the mTOR Signaling Pathway.

Mengjun Pang, Xiaomeng Xie, Yuanyuan Zhang, Kyle Vaughn Laster, Kangdong Liu, Dong Joon Kim

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Ethyl ferulate attenuates allergic asthma via inhibiting macrophage M2 polarization through STAT6/IRF4 pathway.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. New Phenylpropanoid fromCurrent pharmaceutical design · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mengjun PangThe Pathophysiology Department, The School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Xiaomeng XieThe Pathophysiology Department, The School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Yuanyuan ZhangChina-US (Henan) Hormel Cancer Institute, Zhengzhou, China.
Kyle Vaughn LasterChina-US (Henan) Hormel Cancer Institute, Zhengzhou, China.
Kangdong LiuThe Pathophysiology Department, The School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Dong Joon KimThe Pathophysiology Department, The School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
China-US (Henan) Hormel Cancer Institute · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ethyl ferulate is a phenylpropanoid compound isolated from the medicinal herb

Indexed as

cancer growthesophageal squamous cell carcinomaethyl ferulatemTORpatient-derived xenograft

Identifiers

PMID35155187
PMCPMC8833257
OpenAlexW4210428463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.